137 related articles for article (PubMed ID: 9543248)
1. Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: implication in its anti-inflammatory activity.
Abou-Mohamed G; Papapetropoulos A; Catravas JD; Caldwell RW
Eur J Pharmacol; 1998 Jan; 341(2-3):265-72. PubMed ID: 9543248
[TBL] [Abstract][Full Text] [Related]
2. Induction of nitric oxide synthase by endotoxin in rat isolated aorta but not in rat aortic smooth muscle cells grown in culture from explant.
McKendrick JD; Paisley K; Eason S; Mian KB; Martin W
Arch Int Pharmacodyn Ther; 1995; 330(2):206-24. PubMed ID: 8861713
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
Beasley D; McGuiggin M
J Exp Med; 1994 Jan; 179(1):71-80. PubMed ID: 7505803
[TBL] [Abstract][Full Text] [Related]
5. HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro.
Abou-Mohamed G; Papapetropoulos A; Ulrich D; Catravas JD; Tuttle RR; Caldwell RW
J Pharmacol Exp Ther; 1995 Nov; 275(2):584-91. PubMed ID: 7473142
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
7. Factors contributing to differences in the regulation of cGMP in isolated porcine pulmonary vessels.
Bina S; Hart JL; Sei Y; Muldoon SM
Eur J Pharmacol; 1998 Jun; 351(2):253-60. PubMed ID: 9687010
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and cGMP mediate alpha1D-adrenergic receptor-Stimulated protein secretion and p42/p44 MAPK activation in rat lacrimal gland.
Hodges RR; Shatos MA; Tarko RS; Vrouvlianis J; Gu J; Dartt DA
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2781-9. PubMed ID: 16043851
[TBL] [Abstract][Full Text] [Related]
9. Insulin inhibits migration of vascular smooth muscle cells with inducible nitric oxide synthase.
Kahn AM; Allen JC; Seidel CL; Zhang S
Hypertension; 2000 Jan; 35(1 Pt 2):303-6. PubMed ID: 10642315
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the nitric oxide synthase-nitric oxide-cGMP pathway in rat mesenteric endothelial cells.
Papapetropoulos A; Andreopoulos S; Go CY; Hoque A; Fuchs LC; Catravas JD
J Appl Physiol (1985); 2001 Dec; 91(6):2553-60. PubMed ID: 11717218
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
12. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
[TBL] [Abstract][Full Text] [Related]
13. Induction of nitric oxide synthase by protein synthesis inhibition in aortic smooth muscle cells.
Marczin N; Go CY; Papapetropoulos A; Catravas JD
Br J Pharmacol; 1998 Mar; 123(5):1000-8. PubMed ID: 9535031
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
15. Cyclic nucleotides and inducible nitric oxide synthesis in pulmonary artery smooth muscle.
Hayden MA; Nakayama DK
J Surg Res; 1999 Apr; 82(2):222-7. PubMed ID: 10090833
[TBL] [Abstract][Full Text] [Related]
16. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
[TBL] [Abstract][Full Text] [Related]
17. Comparison between endothelial and neuronal nitric oxide pathways in rat aorta and gastric fundus.
Guilmard C; Auguet M; Chabrier PE
Nitric Oxide; 1998; 2(3):147-54. PubMed ID: 9731632
[TBL] [Abstract][Full Text] [Related]
18. Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.
Darblade B; Batkai S; Caussé E; Gourdy P; Fouque MJ; Rami J; Arnal JF
J Vasc Res; 2001; 38(3):266-75. PubMed ID: 11399899
[TBL] [Abstract][Full Text] [Related]
19. Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide.
Wileman SM; Mann GE; Baydoun AR
Br J Pharmacol; 1995 Dec; 116(8):3243-50. PubMed ID: 8719803
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]